INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Schonfeld Strategic Advisors LLC's Holding History (CIK: 0001665241)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 382,233 Value ($000) $50,424 Avg Close — Range —
Q4 2024
Shares 20,540 Value ($000) $1,716 Avg Close — Range —
Q3 2024
Shares 20,737 Value ($000) $1,517 Avg Close — Range —
Q2 2024
Shares 134,454 Value ($000) $9,209 Avg Close — Range —
Q1 2024
Shares 24,418 Value ($000) $1,690 Avg Close — Range —
Q4 2023
Shares 166,121 Value ($000) $11,898 Avg Close — Range —
Q3 2022
Shares 32,071 Value ($000) $1,493 Avg Close — Range —
Q2 2022
Shares 63,201 Value ($000) $3,608 Avg Close — Range —
Q1 2022
Shares 97,925 Value ($000) $5,992 Avg Close — Range —
Q4 2021
Shares 21,715 Value ($000) $1,137 Avg Close — Range —
Q3 2017
Shares 131,980 Value ($000) $2,083 Avg Close — Range —
Q1 2017
Shares 30,989 Value ($000) $504 Avg Close — Range —
Q2 2016
Shares 11,871 Value ($000) $460 Avg Close — Range —